Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fitter

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|August 6, 2005
Deconvolution of a complex target using DNA aptamersStephen Fitter, Robert James
Obesity Research & Clinical Practice|June 20, 2018
Osteopontin in the pathophysiology of obesity: Is Opn a fat cell foe?Stephen Fitter, Andrew C W Zannettino
Journal of Molecular Endocrinology|April 5, 2012
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretionStephen Fitter, Kate Vandyke, Stan Gronthos, et al.
Stem Cells (Dayton, Ohio)|December 28, 2016
The Mesenchymal Precursor Cell Marker Antibody STRO-1 Binds to Cell Surface Heat Shock Cognate 70Stephen Fitter, Stan Gronthos, Soo Siang Ooi, et al.
Blood|November 6, 2009
Dysregulation of bone remodeling by imatinib mesylateKate Vandyke, Stephen Fitter, Andrea L Dewar, et al.
Cancer Metastasis Reviews|August 5, 2024
Molecular and cellular mechanisms of chemoresistance in paediatric pre-B cell acute lymphoblastic leukaemiaCaleb B Lill, Stephen Fitter, Andrew C W Zannettino, et al.
Leukemia Research|January 28, 2015
The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myelomaSally K Martin, Zhen Ying Gan, Stephen Fitter, et al.
Stem Cells and Development|December 27, 2007
A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cellsStan Gronthos, Stephen Fitter, Peter Diamond, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2010
Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?Stephen Fitter, Kate Vandyke, Christopher G Schultz, et al.
European Journal of Haematology|September 3, 2014
The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myelomaZhen Ying Gan, Stephen Fitter, Kate Vandyke, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 6, 2005
Deconvolution of a complex target using DNA aptamersStephen Fitter, Robert James
Obesity Research & Clinical Practice|June 20, 2018
Osteopontin in the pathophysiology of obesity: Is Opn a fat cell foe?Stephen Fitter, Andrew C W Zannettino
Journal of Molecular Endocrinology|April 5, 2012
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretionStephen Fitter, Kate Vandyke, Stan Gronthos, et al.
Stem Cells (Dayton, Ohio)|December 28, 2016
The Mesenchymal Precursor Cell Marker Antibody STRO-1 Binds to Cell Surface Heat Shock Cognate 70Stephen Fitter, Stan Gronthos, Soo Siang Ooi, et al.
Blood|November 6, 2009
Dysregulation of bone remodeling by imatinib mesylateKate Vandyke, Stephen Fitter, Andrea L Dewar, et al.
Cancer Metastasis Reviews|August 5, 2024
Molecular and cellular mechanisms of chemoresistance in paediatric pre-B cell acute lymphoblastic leukaemiaCaleb B Lill, Stephen Fitter, Andrew C W Zannettino, et al.
Leukemia Research|January 28, 2015
The effect of the PI3K inhibitor BKM120 on tumour growth and osteolytic bone disease in multiple myelomaSally K Martin, Zhen Ying Gan, Stephen Fitter, et al.
Stem Cells and Development|December 27, 2007
A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cellsStan Gronthos, Stephen Fitter, Peter Diamond, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2010
Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?Stephen Fitter, Kate Vandyke, Christopher G Schultz, et al.
European Journal of Haematology|September 3, 2014
The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myelomaZhen Ying Gan, Stephen Fitter, Kate Vandyke, et al.
Pageof 3